"Impact of Digital Engagement on Weight Loss Outcomes in Obesity Management Among Individuals Using GLP-1 and Dual GLP-1/GIP Receptor Agonist Therapy: Retrospective Cohort Service Evaluation Study", vol 27 (2025), 31.03.2025, https://www.jmir.org/2025/1/e69466
Aronne, Louis J., et al. “Continued Treatment with Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity: The SURMOUNT-4 Randomized Clinical Trial.” JAMA, vol. 331, no. 1, 11 Dec. 2023, jamanetwork.com/journals/jama/fullarticle/2812936, https://doi.org/10.1001/jama.2023.24945.
“FDA Approves New Medication for Chronic Weight Management.” FDA, 8 Nov. 2023, www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management.
“How Mounjaro® Works | Mounjaro® (Tirzepatide).” Mounjaro.lilly.com, mounjaro.lilly.com/hcp/how-mounjaro-works.
Lin, Fei, et al. “Weight Loss Efficiency and Safety of Tirzepatide: A Systematic Review.” PLOS One, vol. 18, no. 5, 4 May 2023, doi:10.1371/journal.pone.0285197.
“Tirzepatide For Managing Overweight And Obesity [ID6179].” National Institute For Health And Care Excellence. https://www.nice.org.uk/guidance/indevelopment/gid-ta11156. Accessed 13 Nov. 2024.